Literature DB >> 7621599

Tetanus toxoid-specific T cell responses in severe combined immunodeficiency (SCID) mice reconstituted with human peripheral blood lymphocytes.

R Somasundaram1, L Jacob, D Herlyn.   

Abstract

SCID mice reconstituted with human peripheral blood lymphocytes (PBL) have repeatedly been shown to produce antigen-specific B cell responses. We have derived tetanus toxoid (TT)-specific human T cell lines from cells of the peritoneal cavity, spleen and lymph nodes of SCID mice reconstituted with human PBL and boosted with TT. Establishment of these cell lines was dependent on the time interval between reconstitution of the mice with human PBL and initiation of lymphocyte cultures in vitro. When lymphocytes were collected from the mice 8 weeks after reconstitution, human lymphocytes with TT-specific proliferative activity in vitro were isolated from the peritoneal cavity and spleen, but long-term cell lines could not be established after repeated lymphocyte stimulation with TT, IL-2 and autologous Epstein-Barr virus-transformed B cells. In contrast, three long-term (> 10 months) TT-specific human T cell lines were established from lymphocytes collected from two of the eight mice in the group 4 weeks after reconstitution. The T cell lines were either CD4+ (two lines derived from peritoneal cavity and lymph node, respectively) or CD8+ (one line derived from spleen) and all expressed CD3, T cell receptor alpha/beta, and human histocompatibility leucocyte class I antigen. The T cell lines, however, lacked cytotoxic, helper and suppressor activities. Thus, SCID mice can support human T cells that actively migrate to various organs and respond to antigenic stimuli both in vivo and in vitro, but these T cells lack characteristic functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7621599      PMCID: PMC1553294          DOI: 10.1111/j.1365-2249.1995.tb02283.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Interleukin-2 mediated regulation of mitogen-activated T cell reactivity from different lymphoid sources in patients with squamous cell carcinoma of the oral cavity.

Authors:  P S Murali; R Somasundaram; R S Rao; A R Fakih; S G Gangal
Journal:  J Oral Pathol Med       Date:  1989-07       Impact factor: 4.253

2.  Rearrangement of antigen receptor genes is defective in mice with severe combined immune deficiency.

Authors:  W Schuler; I J Weiler; A Schuler; R A Phillips; N Rosenberg; T W Mak; J F Kearney; R P Perry; M J Bosma
Journal:  Cell       Date:  1986-09-26       Impact factor: 41.582

3.  Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse.

Authors:  B A Vandekerckhove; J F Krowka; J M McCune; J E de Vries; H Spits; M G Roncarolo
Journal:  J Immunol       Date:  1991-06-15       Impact factor: 5.422

4.  Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.

Authors:  M L Alegre; L J Peterson; D R Jeyarajah; M Weiser; J A Bluestone; J R Thistlethwaite
Journal:  J Immunol       Date:  1994-09-15       Impact factor: 5.422

5.  In vitro generation of effector cells cytotoxic to autologous targets from chronic myeloid leukemia patients in remission.

Authors:  R Somasundaram; S G Rao; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  An in vivo model of somatic cell gene therapy for human severe combined immunodeficiency.

Authors:  G Ferrari; S Rossini; R Giavazzi; D Maggioni; N Nobili; M Soldati; G Ungers; F Mavilio; E Gilboa; C Bordignon
Journal:  Science       Date:  1991-03-15       Impact factor: 47.728

7.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

8.  Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent.

Authors:  J F Krowka; S Sarin; R Namikawa; J M McCune; H Kaneshima
Journal:  J Immunol       Date:  1991-06-01       Impact factor: 5.422

9.  Transfer of a functional human immune system to mice with severe combined immunodeficiency.

Authors:  D E Mosier; R J Gulizia; S M Baird; D B Wilson
Journal:  Nature       Date:  1988-09-15       Impact factor: 49.962

10.  Gamma interferon and lymphotoxin, released by activated T cells, synergize to inhibit granulocyte/monocyte colony formation.

Authors:  M Murphy; R Loudon; M Kobayashi; G Trinchieri
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

View more
  3 in total

1.  Antigen-specific T cell responses in human peripheral blood leucocyte (hu-PBL)-mouse chimera conditioned with radiation and an antibody directed against the mouse IL-2 receptor beta-chain.

Authors:  T Cao; G Leroux-Roels
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Amelioration of lupus manifestations by a peptide based on the complementarity determining region 1 of an autoantibody in severe combined immunodeficient (SCID) mice engrafted with peripheral blood lymphocytes of systemic lupus erythematosus (SLE) patients.

Authors:  N Mauermann; Z Sthoeger; H Zinger; E Mozes
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

Review 3.  Animal models of human-derived cancer vaccines.

Authors:  D Herlyn; R Somasundaram; W Li; L Jacob
Journal:  Cell Biophys       Date:  1995-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.